Skip to Content

Fluocinolone Topical Dosage

Applies to the following strength(s): 0.01% ; 0.025% ; 0.2%

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Seborrheic Dermatitis

No more than one ounce of the shampoo should be applied to the scalp area once a day, worked into a lather and allowed to remain on the scalp for approximately 5 minutes

Comments:
-Hair and scalp should be rinsed thoroughly with water.

Use: Treatment of seborrheic dermatitis of the scalp

Usual Adult Dose for Psoriasis

Apply a thin film on the scalp, massage well and cover scalp with the supplied shower cap.

Comments:
-Wet or dampen hair and scalp thoroughly
-Leave the oil on overnight or for a minimum of 4 hours before washing it off
-Wash hair with regular shampoo and rinse thoroughly

Use: Treatment of psoriasis of the scalp

Usual Adult Dose for Dermatitis

Apply a thin film to the affected area two to four times a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
-If an infection occurs, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Eczema

Apply a thin film to the affected area two to four times a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
-If an infection occurs, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Atopic Dermatitis

Topical (body) oil: Apply a thin film to the affected areas three times a day

Comments:
-Use should be discontinued when control of disease is achieved.
-If no improvement is seen within 2 weeks, a healthcare provider should be contacted.

Use: Treatment of atopic dermatitis

Usual Pediatric Dose for Atopic Dermatitis

3 months and older:
Topical (scalp and body) oil: Apply to affected area twice a day for up to 4 weeks

Comments:
-The oil should not be applied to the diaper area.
-Intertriginous areas should be avoided.
-Safety and effectiveness in pediatric patients younger than 3 months of age have not been established.

Use: Treatment of moderate to severe atopic dermatitis

Usual Pediatric Dose for Seborrheic Dermatitis

No more than one ounce of the shampoo should be applied to the scalp area once a day, worked into a lather and allowed to remain on the scalp for approximately 5 minutes

Comments:
-Safety and effectiveness in children and infants have not been established.
-Hair and scalp should be rinsed thoroughly with water.

Use: Treatment of seborrheic dermatitis of the scalp

Usual Pediatric Dose for Dermatitis

Apply a thin film to the affected area two to four times a day

Comments:
-Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio.
-Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
-If an infection occurs, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Eczema

Apply a thin film to the affected area two to four times a day

Comments:
-Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio.
-Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
-If an infection occurs, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy in pediatric patients younger than 3 months of age have not been established.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-This drug should not be used on the face, groin, or axillae, unless directed by a healthcare professional.
-The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
-Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.

Storage requirements:
-Excessive heat and freezing should be avoided.

Monitoring:
-Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
-Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.
-This medication is to be used as directed by the physician. It is for external use only. Contact with the eyes should be avoided.
-Patients should be advised not to use this medication for any condition other than for which it was prescribed.

Hide